These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30676753)

  • 1. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.
    Neu HM; Alexishin SA; Brandis JEP; Williams AMC; Li W; Sun D; Zheng N; Jiang W; Zimrin A; Fink JC; Polli JE; Kane MA; Michel SLJ
    Mol Pharm; 2019 Mar; 16(3):1272-1281. PubMed ID: 30676753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
    Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
    Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Non-Transferrin Bound Iron, Transferrin Bound Iron, Drug Bound Iron and Total Iron in Serum in a Rats after IV Administration of Sodium Ferric Gluconate Complex by Simple Ultrafiltration Inductively Coupled Plasma Mass Spectrometric Detection.
    Matta MK; Beekman CR; Gandhi A; Narayanasamy S; Thomas CD; Mohammad A; Stewart S; Xu L; Chockalingam A; Shea K; Patel V; Rouse R
    Nanomaterials (Basel); 2018 Feb; 8(2):. PubMed ID: 29439469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
    Baribeault D
    Curr Med Res Opin; 2011 Aug; 27(8):1653-7. PubMed ID: 21714710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Air-Liquid Interface Cell Exposures to Nanoparticle Aerosols.
    Lewinski NA; Liu NJ; Asimakopoulou A; Papaioannou E; Konstandopoulos A; Riediker M
    Methods Mol Biol; 2017; 1570():301-313. PubMed ID: 28238146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structure.
    Krupnik L; Joshi P; Kappler A; Flühmann B; Alston AB; Digigow R; Wick P; Neels A
    Eur J Pharm Sci; 2023 Sep; 188():106521. PubMed ID: 37423578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
    Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
    Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
    Baribeault D
    Curr Med Res Opin; 2011 Dec; 27(12):2241-3. PubMed ID: 21992082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing Specificity to Iron Oxide Nanoparticle Imaging by Combining
    Masthoff M; Buchholz R; Beuker A; Wachsmuth L; Kraupner A; Albers F; Freppon F; Helfen A; Gerwing M; Höltke C; Hansen U; Rehkämper J; Vielhaber T; Heindel W; Eisenblätter M; Karst U; Wildgruber M; Faber C
    Nano Lett; 2019 Nov; 19(11):7908-7917. PubMed ID: 31556617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars.
    Mühlebach S; Borchard G; Yildiz S
    Nanomedicine (Lond); 2015 Mar; 10(4):659-74. PubMed ID: 25723097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography coupled with inductively coupled plasma mass spectrometry in the pharmaceutical industry: selected examples.
    Marshall PS; Leavens B; Heudi O; Ramirez-Molina C
    J Chromatogr A; 2004 Nov; 1056(1-2):3-12. PubMed ID: 15595526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Oxide Nanoparticle Formulations for Supplementation.
    Pai AB
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
    Pai AB
    Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.
    Pai AB; Pai MP; Meyer DE; Bales BC; Cotero VE; Zheng N; Jiang W
    Regul Toxicol Pharmacol; 2018 Aug; 97():17-23. PubMed ID: 29857115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.
    Wu M; Sun D; Tyner K; Jiang W; Rouse R
    Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29244729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-inductively coupled plasma mass spectrometry.
    Sutton KL; Caruso JA
    J Chromatogr A; 1999 Sep; 856(1-2):243-58. PubMed ID: 10526791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice.
    Nikravesh N; Borchard G; Hofmann H; Philipp E; Flühmann B; Wick P
    Nanomedicine; 2020 Jun; 26():102178. PubMed ID: 32145382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.
    Wu Y; Petrochenko P; Chen L; Wong SY; Absar M; Choi S; Zheng J
    Int J Pharm; 2016 May; 505(1-2):167-74. PubMed ID: 27001529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LA-ICP-MS Allows Quantitative Microscopy of Europium-Doped Iron Oxide Nanoparticles and is a Possible Alternative to Ambiguous Prussian Blue Iron Staining.
    Scharlach C; Müller L; Wagner S; Kobayashi Y; Kratz H; Ebert M; Jakubowski N; Schellenberger E
    J Biomed Nanotechnol; 2016 May; 12(5):1001-10. PubMed ID: 27305821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.